| 持有 上海医药(601607)的基金 |
| 报告期：2022-03-31 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 001258 | 兴业收益增强债券C | 208,089,900.00 | 8,490,000.00 | 2.79 |
| 2 | 001257 | 兴业收益增强债券A | 208,089,900.00 | 8,490,000.00 | 2.79 |
| 3 | 006567 | 中泰星元灵活配置混合 | 165,012,055.38 | 6,732,438.00 | 3.74 |
| 4 | 005985 | 兴业聚华混合C | 108,701,850.00 | 4,435,000.00 | 3.04 |
| 5 | 005984 | 兴业聚华混合A | 108,701,850.00 | 4,435,000.00 | 3.04 |
| 6 | 006624 | 中泰玉衡价值优选混合 | 67,254,410.58 | 2,743,958.00 | 3.79 |
| 7 | 000893 | 工银创新动力股票 | 48,529,800.00 | 1,980,000.00 | 4.39 |
| 8 | 001551 | 天弘中证医药100指数C | 18,305,489.58 | 746,858.00 | 1.40 |
| 9 | 001550 | 天弘中证医药100指数A | 18,305,489.58 | 746,858.00 | 1.40 |
| 10 | 008107 | 华商医药医疗行业股票 | 6,127,500.00 | 250,000.00 | 3.90 |
| 11 | 008222 | 兴业机遇债券C | 3,872,580.00 | 158,000.00 | 2.87 |
| 12 | 005717 | 兴业机遇债券A | 3,872,580.00 | 158,000.00 | 2.87 |
| 13 | 008563 | 银河臻优稳健配置混合A | 3,676,500.00 | 150,000.00 | 0.49 |
| 14 | 008564 | 银河臻优稳健配置混合C | 3,676,500.00 | 150,000.00 | 0.49 |
| 15 | 009789 | 富安达科技创新混合 | 3,431,400.00 | 140,000.00 | 6.08 |
| 16 | 006569 | 国联安医药100指数C | 2,926,959.69 | 119,419.00 | 1.33 |
| 17 | 000059 | 国联安医药100指数A | 2,926,959.69 | 119,419.00 | 1.33 |
| 18 | 510660 | 华夏医药ETF | 2,602,962.00 | 106,200.00 | 2.50 |
| 19 | 004549 | 富安达消费主题混合 | 2,205,900.00 | 90,000.00 | 7.98 |
| 20 | 519623 | 银河君耀混合A | 2,095,605.00 | 85,500.00 | 0.52 |
| 21 | 519624 | 银河君耀混合C | 2,095,605.00 | 85,500.00 | 0.52 |
| 22 | 009502 | 国寿安保创新医药股票A | 1,470,600.00 | 60,000.00 | 2.74 |
| 23 | 009503 | 国寿安保创新医药股票C | 1,470,600.00 | 60,000.00 | 2.74 |
| 24 | 004260 | 德邦稳盈增长灵活配置混合 | 904,419.00 | 36,900.00 | 1.08 |
| 25 | 510190 | 华安上证龙头ETF | 710,790.00 | 29,000.00 | 1.35 |
